跳至主要内容
临床试验/NCT05979597
NCT05979597已完成不适用

The Effect of Adjuvant Dexamethasone on Postoperative Pain, Analgesic Consumption and Block Properties in Suprainguinal Fascia Iliaca Block (SFIB) in Knee Arthroplasty

Samsun Education and Research Hospital2 个研究点 分布在 2 个国家目标入组 80 人开始时间: 2023年8月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Postoperative opioid consumption

研究概览

简要总结

The investigators aimed to demonstrate that dexamethasone added as an adjuvant to local anaesthetic agent in suprainguinal fascia iliaca block for effective postoperative analgesia after knee arthroplasty would prolong the duration of sensory block and reduce postoperative pain intensity and analgesic consumption.

详细描述

Total knee arthroplasty is one of the major orthopedic surgeries that cause severe postoperative pain. A successful post-operative outcome is possible with strong and effective pain control followed by early mobilization and a good functional recovery. Suprainguinal fascia iliaca plan block (SFIB) has been shown to be an effective postoperative method in multimodal analgesia regime in lower extremity surgery. It has been reported in the literature that dexamethasone added to local anaesthetics in peripheral nerve blocks prolongs the duration of sensory block, improves the quality of analgesia, reduces postoperative pain intensity and opioid consumption.

In this study, the investigators aimed to demonstrate that dexamethasone added as an adjuvant to local anaesthetic agent in SFIB for effective postoperative analgesia after knee arthroplasty would prolong the duration of sensory block and reduce postoperative pain intensity and analgesic consumption.

An identification number will be randomly assigned to each participants, whose written consent was obtained before the surgery, when they are admitted to the postoperative recovery room. In the postoperative period, participants will be followed up with these numbers. Which group the participants will be included in will be determined by the closed envelope method.

Participants undergoing unilateral knee arthroplasty will be included in the study. Following the end of surgery, the participants will be divided into two groups in the recovery room and SFIB will be applied to both groups. Participants in group SFIB will receive 0.25% bupivacaine as local anaesthetic. Participants in group SFIB+dexamethasone will receive 0.25% bupivacaine as local anaesthetic and 8 mg dexamethasone as adjuvant.

The participant with the block will be followed in the recovery room and if the block is successful, morphine patient controlled analgesia (PCA) treatment will be started and the participant will be taken to the ward. A standard analgesia regimen (1 g iv paracetamol every 8 hours, 50 mg iv dexketoprofen every 12 hours) was used in all participants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The patient will not know which study group he is in. The anesthetist, who will perform the regional block, will give the block to be applied in a sealed envelope by an assistant staff outside the study, and at the same time, the patient will not know which block has been made. The anesthesiologist who made the block will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another investigator blinded to the study.

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having undergone unilateral knee replacement surgery under elective conditions,
  • Age range of 18-75 years,
  • American Society of Anesthesiologist's physiologic state I-III patients,
  • written consent who agreed to participate in the study.

排除标准

  • who do not want to be included in the study by not signing the voluntary consent form,
  • Local infection, hematoma, hernia, neoplasm etc. in the area to be blocked. found,
  • Coagulopathy, hepatic or renal failure,
  • Allergic to a local anesthetic agent or one of the drugs used in the study,
  • Having a history of chronic opioid and corticosteroid use,
  • who cannot use the patient-controlled analgesia system and have a psychiatric disease,
  • with operative time less than 20 minutes and more than 120 minutes for better standardization of studies.

结局指标

主要结局

Postoperative opioid consumption

时间窗: Postoperative 24 hours

First 24 hours total morphine consumption with patient controlled analgesia

次要结局

  • Timed up and go test (TUG)(at 24th hour)
  • Numerical Rating Scale(Postoperative 24 hours)
  • Quadriceps muscle strength(at 24th hour)

研究者

发起方
Samsun Education and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hale Kefeli Celik

Anesthesiologist, Principal Investigator

Samsun Education and Research Hospital

研究点 (2)

Loading locations...

相似试验

The Effect of Adjuvant Dexamethasone on... | 临床试验